Nuvalent Inc (NUVL)
Healthcare
Biotechnology
124.00 $
+0.0%
vs. previous close
Closing price · As of: 21. Jul 2026
Nuvalent Inc (NUVL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -275 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -9.6 | -15 | -40 | -65 | -100 | -185 | -275 | |
| – | – | 0.2 | -0.4 | – | – | – | |
| 0.0 | 0.7 | 3.6 | 10 | 26 | 61 | 87 | |
| 1.6 | -1.7 | 3.6 | 10 | – | – | – | |
| 0.6 | 1.3 | 1.9 | 6.9 | 11 | 12 | 19 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -220 | -220 | -220 | -11 | -144 | -574 | -124 | |
| – | – | 319 | 250 | 0.4 | – | – | |
| -0.3 | -0.3 | 0.3 | 0.0 | – | – | – | |
| 22 | 22 | 318 | 249 | 337 | 569 | 515 | |
| -9.6 | 7.3 | 58 | 173 | 94 | -190 | 116 | |
| -9.6 | -15 | -40 | -65 | -100 | -185 | -275 |
Data as of: July 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.